Excretion of tolbutamide metabolites in young and old subjects

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02336696PMID 2379540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug metabolism in the elderly.

  1988cited by this paper
• Effects of total plasma concentration and age on tolbutamide plasma protein binding

  1982cited by this paper
• Reduced Serum Albumin Concentration in the Elderly: A Report from the Boston Collaborative Drug Surveillance Program

  1979cited by this paper
• Tolbutamide binding to plasma proteins of young and old human subjects.

  1978cited by this paper
• The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study.

  1976cited by this paper
• Pharmacokinetics in the Elderly

  1976cited by this paper
• Simultaneous Determination of Tolbutamide and its Metabolites in Biological Fluids

  1973cited by this paper
• Abbauhemmung von tolbutamid durch sulfaphenazol beim menschen

  1970influential reference
• The metabolic fate of tolbutamide in man and in the rat.

  1966influential reference

• Evaluation of small interfering RNA-dependent knockdowns of drug-metabolizing enzymes in multiwell array culture of primary human hepatocyte spheroids for estimation of fraction metabolized.

  2025cites this paper
• Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450

  2021cites this paper
• Physiologically‐Based Pharmacokinetic Modeling Combined with Swiss HIV Cohort Study Data Supports No Dose Adjustment of Bictegravir in Elderly Individuals Living With HIV

  2021cites this paper
• Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam

  2017cites this paper
• On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination

  2016cites this paper
• Novel Cytochrome P450 Reaction Phenotyping for Low-Clearance Compounds Using the Hepatocyte Relay Method

  2016cites this paper
• Novel Cytochrome P450 Reaction Phenotyping for Low Clearance Compounds Using Hepatocyte Relay Method

  2015cites this paper
• The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.

  2011cites this paper
• Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics

  2008cites this paper
• Inhibition-based metabolic drug-drug interactions: predictions from in vitro data.

  2002cites this paper
• Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.

  2000cites this paper
• The Use of Sulphonylureas in the Elderly

  1999cites this paper
• Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.

  1997cites this paper
• REVIEW ARTICLE PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKTNETICS

  1996cites this paper
• PREDICTION OF IN VIVO DRUG DISPOSITION FROM IN VITRO DATA BASED ON PHYSIOLOGICAL PHARMACOKINETICS

  1996cites this paper
• [Pharmacokinetics in the aged].

  1992cites this paper